{"formats":[{"name":"JSON","format":"json","url":"\/downloads\/2025\/code-json\/54.1-2520.json"},{"name":"Plain Text","format":"text","url":"\/downloads\/2025\/code-text\/54.1-2520.txt"},{"name":"XML","format":"xml","url":"\/downloads\/2025\/code-xml\/54.1-2520.xml"},{"name":"HTML","format":"html","url":"\/downloads\/2025\/code-html\/54.1-2520.html"}],"law_id":55075,"edition_id":1,"section_id":55075,"structure_id":13315,"section_number":"54.1-2520","catch_line":"Program establishment; Director&#8217;s regulatory authority","history":"2002, c. 481; 2005, cc. 637, 678; 2014, c. 664; 2016, cc. 410, 568; 2018, cc. 185, 379.","full_text":"A\n\nThe Director shall establish, maintain, and administer an electronic system to monitor the dispensing of covered substances to be known as the Prescription Monitoring Program.B\n\nThe Director, after consultation with relevant health regulatory boards, shall promulgate, in accordance with the provisions of the Administrative Process Act (&#xA7; 2.2-4000 et seq.), such regulations as are necessary to implement the prescription monitoring program as provided in this chapter, including, but not limited to, the establishment of criteria for granting waivers of the reporting requirements set forth in &#xA7; 54.1-2521.C\n\nThe Director may enter into contracts as may be necessary for the implementation and maintenance of the Prescription Monitoring Program.D\n\nThe Director shall provide dispensers with a basic file layout to enable electronic transmission of the information required in this chapter. For those dispensers unable to transmit the required information electronically, the Director shall provide an alternative means of data transmission.E\n\nThe Director shall also establish an advisory committee within the Department to assist in the implementation and evaluation of the Prescription Monitoring Program. Such advisory committee shall provide guidance to the Director regarding information disclosed pursuant to subdivision C 9 of &#xA7; 54.1-2523.","order_by":null,"text":{"0":{"id":201989,"text":"The Director shall establish, maintain, and administer an electronic system to monitor the dispensing of covered substances to be known as the Prescription Monitoring Program.","type":"section","prefixes":["A"],"prefix":"A","entire_prefix":"A","prefix_anchor":"A","level":1,"next_prefix":"B"},"1":{"id":201990,"text":"The Director, after consultation with relevant health regulatory boards, shall promulgate, in accordance with the provisions of the Administrative Process Act (&#xA7; 2.2-4000 et seq.), such regulations as are necessary to implement the prescription monitoring program as provided in this chapter, including, but not limited to, the establishment of criteria for granting waivers of the reporting requirements set forth in &#xA7; 54.1-2521.","type":"section","prefixes":["B"],"prefix":"B","entire_prefix":"B","prefix_anchor":"B","level":1,"prior_prefix":"A","next_prefix":"C"},"2":{"id":201991,"text":"The Director may enter into contracts as may be necessary for the implementation and maintenance of the Prescription Monitoring Program.","type":"section","prefixes":["C"],"prefix":"C","entire_prefix":"C","prefix_anchor":"C","level":1,"prior_prefix":"B","next_prefix":"D"},"3":{"id":201992,"text":"The Director shall provide dispensers with a basic file layout to enable electronic transmission of the information required in this chapter. For those dispensers unable to transmit the required information electronically, the Director shall provide an alternative means of data transmission.","type":"section","prefixes":["D"],"prefix":"D","entire_prefix":"D","prefix_anchor":"D","level":1,"prior_prefix":"C","next_prefix":"E"},"4":{"id":201993,"text":"The Director shall also establish an advisory committee within the Department to assist in the implementation and evaluation of the Prescription Monitoring Program. Such advisory committee shall provide guidance to the Director regarding information disclosed pursuant to subdivision C 9 of &#xA7; 54.1-2523.","type":"section","prefixes":["E"],"prefix":"E","entire_prefix":"E","prefix_anchor":"E","level":1,"prior_prefix":"D"}},"ancestry":[{"id":13315,"edition_id":1,"name":"Prescription Monitoring Program","identifier":"25.2","label":"chapter","depth":3,"order_by":1,"parent_id":12758,"metadata":{},"date_created":"2026-06-26 03:44:37","date_modified":"2026-06-26 03:44:37","permalink":{"id":241371,"object_type":"structure","relational_id":13315,"identifier":"25.2","token":"54.1\/III\/25.2","url":"\/54.1\/III\/25.2\/","edition_id":1,"permalink":0,"preferred":1}},{"id":12758,"edition_id":1,"name":"Professions and Occupations Regulated by Boards Within the Department of Health Professions","identifier":"III","label":"subtitle","depth":2,"order_by":1,"parent_id":12754,"metadata":{},"date_created":"2026-06-26 03:43:51","date_modified":"2026-06-26 03:43:51","permalink":{"id":241105,"object_type":"structure","relational_id":12758,"identifier":"III","token":"54.1\/III","url":"\/54.1\/III\/","edition_id":1,"permalink":0,"preferred":1}},{"id":12754,"edition_id":1,"name":"Professions and Occupations","identifier":"54.1","label":"title","depth":1,"order_by":1,"parent_id":null,"metadata":{},"date_created":"2026-06-26 03:43:51","date_modified":"2026-06-26 03:43:51","permalink":{"id":239313,"object_type":"structure","relational_id":12754,"identifier":"54.1","token":"54.1","url":"\/54.1\/","edition_id":1,"permalink":0,"preferred":1}}],"structure_contents":[{"id":68394,"structure_id":13315,"section_number":"54.1-2519","catch_line":"Definitions","url":"\/54.1-2519\/","token":"54.1\/III\/25.2\/54.1-2519","metadata":false},{"id":55075,"structure_id":13315,"section_number":"54.1-2520","catch_line":"Program establishment; Director's regulatory authority","url":"\/54.1-2520\/","token":"54.1\/III\/25.2\/54.1-2520","metadata":false},{"id":64843,"structure_id":13315,"section_number":"54.1-2521","catch_line":"(Effective July 1, 2026) Reporting requirements","url":"\/54.1-2521\/","token":"54.1\/III\/25.2\/54.1-2521","metadata":false},{"id":69685,"structure_id":13315,"section_number":"54.1-2522","catch_line":"(Effective July 1, 2026) Reporting exemptions","url":"\/54.1-2522\/","token":"54.1\/III\/25.2\/54.1-2522","metadata":false},{"id":72705,"structure_id":13315,"section_number":"54.1-2522.1","catch_line":"(Effective July 1, 2027) Requirements of practitioners","url":"\/54.1-2522.1\/","token":"54.1\/III\/25.2\/54.1-2522.1","metadata":false},{"id":67799,"structure_id":13315,"section_number":"54.1-2522.2","catch_line":"Requirements for dispensers","url":"\/54.1-2522.2\/","token":"54.1\/III\/25.2\/54.1-2522.2","metadata":false},{"id":56919,"structure_id":13315,"section_number":"54.1-2523","catch_line":"Confidentiality of data; disclosure of information; discretionary authority of Director","url":"\/54.1-2523\/","token":"54.1\/III\/25.2\/54.1-2523","metadata":false},{"id":74465,"structure_id":13315,"section_number":"54.1-2523.1","catch_line":"Criteria for indicators of misuse; Director's authority to disclose information; intervention","url":"\/54.1-2523.1\/","token":"54.1\/III\/25.2\/54.1-2523.1","metadata":false},{"id":56473,"structure_id":13315,"section_number":"54.1-2523.2","catch_line":"(Effective July 1, 2027) Authority to access database","url":"\/54.1-2523.2\/","token":"54.1\/III\/25.2\/54.1-2523.2","metadata":false},{"id":57186,"structure_id":13315,"section_number":"54.1-2524","catch_line":"Immunity from liability","url":"\/54.1-2524\/","token":"54.1\/III\/25.2\/54.1-2524","metadata":false},{"id":57288,"structure_id":13315,"section_number":"54.1-2525","catch_line":"Unlawful disclosure of information; disciplinary action authorized; penalties","url":"\/54.1-2525\/","token":"54.1\/III\/25.2\/54.1-2525","metadata":false},{"id":54302,"structure_id":13315,"section_number":"54.1-2526","catch_line":"Exemption of information systems from provisions related to the Virginia Information Technologies Agency","url":"\/54.1-2526\/","token":"54.1\/III\/25.2\/54.1-2526","metadata":false}],"previous_section":{"id":68394,"structure_id":13315,"section_number":"54.1-2519","catch_line":"Definitions","url":"\/54.1-2519\/","token":"54.1\/III\/25.2\/54.1-2519","metadata":false},"next_section":{"id":64843,"structure_id":13315,"section_number":"54.1-2521","catch_line":"(Effective July 1, 2026) Reporting requirements","url":"\/54.1-2521\/","token":"54.1\/III\/25.2\/54.1-2521","metadata":false},"metadata":false,"official_url":"https:\/\/law.lis.virginia.gov\/vacode\/54.1-2520\/","history_text":"<p>This law was first created in 2002. The record of its establishment is cataloged in chapter <a href=\"https:\/\/legacylis.virginia.gov\/cgi-bin\/legp604.exe?021+ful+CHAP0481\">481<\/a> of that year\u2019s edition of \u201cActs of Assembly,\u201d the annual state publication listing all changes made to the Code of Virginia in that year. It has been modified 4 times. Those modifications are cataloged by \u201cThe Acts of Assembly,\u201d a state publication, by year and chapter. Those modifications that can be read on the General Assembly\u2019s website will be linked accordingly. Those modifications are as follows: in 2005, chapters <a href=\"https:\/\/legacylis.virginia.gov\/cgi-bin\/legp604.exe?051+ful+CHAP0637\">637<\/a> and <a href=\"https:\/\/legacylis.virginia.gov\/cgi-bin\/legp604.exe?051+ful+CHAP0678\">678<\/a>; in 2014, chapter <a href=\"https:\/\/legacylis.virginia.gov\/cgi-bin\/legp604.exe?141+ful+CHAP0664\">664<\/a>; in 2016, chapters <a href=\"https:\/\/legacylis.virginia.gov\/cgi-bin\/legp604.exe?161+ful+CHAP0410\">410<\/a> and <a href=\"https:\/\/legacylis.virginia.gov\/cgi-bin\/legp604.exe?161+ful+CHAP0568\">568<\/a>; in 2018, chapters <a href=\"https:\/\/legacylis.virginia.gov\/cgi-bin\/legp604.exe?181+ful+CHAP0185\">185<\/a> and <a href=\"https:\/\/legacylis.virginia.gov\/cgi-bin\/legp604.exe?181+ful+CHAP0379\">379<\/a>.<\/p>","references":[{"id":77566,"section_number":"32.1-276.6","catch_line":"Patient level data system continued; reporting requirements","order_by":null,"url":"\/32.1-276.6\/"}],"refers_to":[{"id":86911,"section_number":"2.2-4000","catch_line":"Short title; purpose","order_by":null,"url":"\/2.2-4000\/"},{"id":56919,"section_number":"54.1-2523","catch_line":"Confidentiality of data; disclosure of information; discretionary authority of Director","order_by":null,"url":"\/54.1-2523\/"}],"permalink":{"id":241377,"object_type":"law","relational_id":55075,"identifier":"54.1-2520","token":"54.1\/III\/25.2\/54.1-2520","url":"\/54.1-2520\/","edition_id":1,"permalink":0,"preferred":1},"url":"\/54.1-2520\/","token":"54.1\/III\/25.2\/54.1-2520","dublin_core":{"Title":"Program establishment; Director&#8217;s regulatory authority","Type":"Text","Format":"text\/html","Identifier":"\u00a7 54.1-2520","Relation":"Code of Virginia"},"html":"\n\t\t\t\t\t\t<section id=\"A\"><p><span class=\"prefix-number\">A.<\/span> The <span class=\"dictionary\">Director<\/span> shall establish, maintain, and <span class=\"dictionary\">administer<\/span> an electronic system to monitor the dispensing of <span class=\"dictionary\">covered substances<\/span> to be known as the Prescription Monitoring Program. <a id=\"paragraph-201989\" class=\"section-permalink\" href=\"https:\/\/vacode.org\/54.1-2520\/#A\"><i class=\"fa fa-link\"><\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t<section id=\"B\"><p><span class=\"prefix-number\">B.<\/span> The <span class=\"dictionary\">Director<\/span>, after consultation with <span class=\"dictionary\">relevant health regulatory boards<\/span>, shall promulgate, in accordance with the provisions of the Administrative Process Act (&#xA7; <a class=\"law\" title=\"Short title; purpose\" href=\"\/2.2-4000\/\">2.2-4000<\/a> et seq.), such regulations as are necessary to implement the prescription monitoring program as provided in this chapter, including, but not limited to, the establishment of criteria for granting <span class=\"dictionary\">waivers<\/span> of the reporting requirements set forth in &#xA7; <a class=\"law\" title=\"(Effective July 1, 2026) Reporting requirements\" href=\"\/54.1-2521\/\">54.1-2521<\/a>. <a id=\"paragraph-201990\" class=\"section-permalink\" href=\"https:\/\/vacode.org\/54.1-2520\/#B\"><i class=\"fa fa-link\"><\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t<section id=\"C\"><p><span class=\"prefix-number\">C.<\/span> The <span class=\"dictionary\">Director<\/span> may enter into <span class=\"dictionary\">contracts<\/span> as may be necessary for the implementation and maintenance of the Prescription Monitoring Program. <a id=\"paragraph-201991\" class=\"section-permalink\" href=\"https:\/\/vacode.org\/54.1-2520\/#C\"><i class=\"fa fa-link\"><\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t<section id=\"D\"><p><span class=\"prefix-number\">D.<\/span> The <span class=\"dictionary\">Director<\/span> shall provide <span class=\"dictionary\">dispensers<\/span> with a basic file layout to enable electronic transmission of the information required in this chapter. For those <span class=\"dictionary\">dispensers<\/span> unable to transmit the required information electronically, the <span class=\"dictionary\">Director<\/span> shall provide an alternative means of data transmission. <a id=\"paragraph-201992\" class=\"section-permalink\" href=\"https:\/\/vacode.org\/54.1-2520\/#D\"><i class=\"fa fa-link\"><\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t<section id=\"E\"><p><span class=\"prefix-number\">E.<\/span> The <span class=\"dictionary\">Director<\/span> shall also establish an advisory committee within the <span class=\"dictionary\">Department<\/span> to assist in the implementation and evaluation of the Prescription Monitoring Program. Such advisory committee shall provide guidance to the <span class=\"dictionary\">Director<\/span> regarding information disclosed pursuant to subdivision C 9 of &#xA7; <a class=\"law\" title=\"Confidentiality of data; disclosure of information; discretionary authority of Director\" href=\"\/54.1-2523\/\">54.1-2523<\/a>. <a id=\"paragraph-201993\" class=\"section-permalink\" href=\"https:\/\/vacode.org\/54.1-2520\/#E\"><i class=\"fa fa-link\"><\/i><\/a><\/p><\/section>","plain_text":"                                 CODE OF VIRGINIA\n\nPROGRAM ESTABLISHMENT; DIRECTOR&#8217;S REGULATORY AUTHORITY (\u00a7 54.1-2520)\n\nA. The Director shall establish, maintain, and administer an electronic system\nto monitor the dispensing of covered substances to be known as the Prescription\nMonitoring Program.\n\nB. The Director, after consultation with relevant health regulatory boards,\nshall promulgate, in accordance with the provisions of the Administrative\nProcess Act (&#xA7; 2.2-4000 et seq.), such regulations as are necessary to\nimplement the prescription monitoring program as provided in this chapter,\nincluding, but not limited to, the establishment of criteria for granting\nwaivers of the reporting requirements set forth in &#xA7; 54.1-2521.\n\nC. The Director may enter into contracts as may be necessary for the\nimplementation and maintenance of the Prescription Monitoring Program.\n\nD. The Director shall provide dispensers with a basic file layout to enable\nelectronic transmission of the information required in this chapter. For those\ndispensers unable to transmit the required information electronically, the\nDirector shall provide an alternative means of data transmission.\n\nE. The Director shall also establish an advisory committee within the Department\nto assist in the implementation and evaluation of the Prescription Monitoring\nProgram. Such advisory committee shall provide guidance to the Director\nregarding information disclosed pursuant to subdivision C 9 of &#xA7; 54.1-2523.\n\nHISTORY: 2002, c. 481; 2005, cc. 637, 678; 2014, c. 664; 2016, cc. 410, 568;\n2018, cc. 185, 379.","edition":{"id":1,"name":"2025","slug":"2025","date_created":"2026-06-21 22:39:22","date_modified":"2026-06-21 22:39:22","current":1,"order_by":1,"last_import":null}}